Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Product: | Adcetris |
| Active Ingredient: | Brentuximab vedotin 50mg |
| Dosage Form: | Powder for injection |
| New Zealand Sponsor: | Takeda New Zealand Limited |
| Manufacturers: | BSP Pharmaceuticals SpA, Latina, Italy Fareva Pau SAS, Idron, France |
Dated this 17th day of April 2023.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).